Medical Retina
3rd ESASO Module 2018
Medical Retina
3rd ESASO Module 2018
c/o Università della Svizzera italiana (USI)
European School for Advanced Studies in Ophthalmology ESASO
c/o Università della Svizzera italiana (USI)
Via G. Buffi 13
CH - 6904 Lugano
Tel.: +41 (0)58 666 46 29
Fax: +41 (0)58 666 46 19
-
Basisinformation
Datum12.02.2018, 07:45 - 16.02.2018, 13:00LehrkursRomeSpracheEnglischCME Max23 CME PunkteGebühren abgebührenfreiVeranstalterEuropean School for Advanced Studies in Ophthalmology ESASO
c/o Università della Svizzera italiana (USI)OrganisatorEuropean School for Advanced Studies in Ophthalmology ESASO
c/o Università della Svizzera italiana (USI)
Via G. Buffi 13
CH - 6904 Lugano
Tel.: +41 (0)58 666 46 29
Fax: +41 (0)58 666 46 19 -
VERANSTALTUNGSORT
Event location is to be verified.
Rome, IT -
Programm
Monday, 12 February 2018 07:45-08:30 Registration and welcoming Intravitreal Injection Course 08:30 Criteria for selection of the treatment and the protocol of treatment (disease, comorbidities, age of the patient, availabilityof the patients, organization of the hospital) 09:15 Prevention of endophthalmitis: selection of the eye, prophylaxis treatment injection and reinjection techniques 10:00 Controls and post-injections treatments 10:30 COFFEE BREAK 11:00 Generic and specific complications per pathology (DME, PDR, RVO, AMD, ROP, Coats, etc.) 12:00 Dealing with post-intravitreal injection endophthalmitis 13:00 LUNCH News In AMD Management 14:00 AMD: AMD treatment with intravitreal aflibercept or ranibizumab: treatment protocols, efficacy, safety and patterns of response 15:00 PCV: from diagnosis to treatment 15:45 COFFEE BREAK 16:15-17:00 Myopic CNV treatment: long-term results and case study Tuesday, 13 February 2018 08:30-13:00 Industry Satellite Symposia 13:00 LUNCH Imaging Course 14:00 DME in imaging and OCT/OCT-A: what is important to know 14:30 OCT classification of drusen and macular atrophy - OCT features in wAMD 15:30 COFFEE BREAK 16:00-17:00 OCT-A features of CNV - OCT and OCT-A integrated images for management of wAMD Wednesday, 14 February 2018 Imaging Course 08:30 Imaging intermediate AMD and subclinical neovascularization 08:50 Different CNV types by OCT-A and evaluation of their activity without use of fluorescein angiography 09:10 “Smart-check” of the imaging to assess the response to AMD treatment 09:30 OCT-A findings of PCV and changes under treatment 09:50 OCT-A findings in CSCR, CNV in CSCR, Mactel I and II 10:10 Clinical value of the imaging assessment of the choroid 10:30 COFFEE BREAK 11:00 Peculiar characteristics of myopic CNV on OCT-A and assessment of response to anti-VEGF treatment 11:20 Managing irvine-gass: OCT assessment of macula prior and after cataract surgery and response to treatment 11:40 Challenges in interpretation of OCT-A images in AMD DME In Real Life 12:00 New aspects of biomicroscopic modification of macular stroma and vascularization in the progression of ME 12:30 Correlation of inflammation biomarkers and the stage of ME 13:00 LUNCH 14:00 DME in imaging and OCT/OCT-A: what is important to know 14:30 Intravitreal steroids: biological and clinical differences 15:00 COFFEE BREAK 15:30 Real life data of DME intravitreal treatments and patients management 16:00-16:30 Intravitreal treatment: burden for patients and payers Thursday, 15 February 2018 09:00 Use of anti-VEGF as prevention of PDR 10:00 Anti-VEGF safety 10:30 COFFEE BREAK 11:00 Combining or switching treatment for DME 11:45 Use of micropulse laser in DME treatment 12:30 Chronic and refractory DME: definition and treatment options 13:00 LUNCH Diabetic Retinopathy And RVO 14:00 Optimized and realistic treatment of DME 14:45 PDR treatment with anti-VEGF: beyond protocol results what is the clinical application? 15:30 COFFEE BREAK 16:00-17:00 Intravitreal steroids and anti-VEGF treatment of ME in RVO: Case study Friday, 16 February 2018 Uveitis Course 08:30 Infectious uveitis manifestations, diagnosis and treatment 09:30 Non-infectious uveitis manifestation and diagnosis and treatment 10:30 COFFEE BREAK 11:00 Deliver of corticosteroids in non-infectious uveitis: systemic, intravitreal, suprachoroidal, subtenonians, subconjunctival 11:30 Case study of infectious uveitis 12:00 Case study of non-infectious uveitis 12:30-13:00 Test, certificates and farewell -
Gebühren
Fachärzte/-innenGebühren abgebührenfreiÄrzte/-innen in WeiterbildungGebühren abgebührenfrei
-
Buchung / Anmeldung
Please contact the organizer for further information.
-
Zertifizierung
Zertifizierung beantragt für 23 CME Punkte bei der European Accreditation Council for Continuing Medical Education (EACCME)